16-29816580-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024516.4(PAGR1):āc.55T>Cā(p.Ser19Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000132 in 1,514,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024516.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAGR1 | NM_024516.4 | c.55T>C | p.Ser19Pro | missense_variant | 1/3 | ENST00000320330.8 | NP_078792.1 | |
MVP-DT | NR_186424.1 | n.246+2960A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAGR1 | ENST00000320330.8 | c.55T>C | p.Ser19Pro | missense_variant | 1/3 | 1 | NM_024516.4 | ENSP00000326519.6 | ||
ENSG00000280893 | ENST00000609618.2 | n.1076T>C | non_coding_transcript_exon_variant | 4/6 | 5 | ENSP00000476774.2 | ||||
MVP-DT | ENST00000569039.5 | n.245+2960A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152030Hom.: 0 Cov.: 32
GnomAD4 exome AF: 7.34e-7 AC: 1AN: 1361942Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 667178
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.55T>C (p.S19P) alteration is located in exon 1 (coding exon 1) of the PAGR1 gene. This alteration results from a T to C substitution at nucleotide position 55, causing the serine (S) at amino acid position 19 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at